Clinical trials recruiting for Neuromyelitis Optica Spectrum Disorder

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• Biomarkers in Autoimmune Disease of Nervous System
  NCT06502015 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)
  NCT06474520 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• French Registry for Monitoring Pregnancies for Multiple Sclerosis
  NCT03900221 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 48 locations
• Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
  NCT04561557 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
  NCT05017142 · Phase: Not specified · Ages: Up to 36 Years · Sex: All (male and female) · 13 locations

Related conditions

Trials recruiting for Neuromyelitis Optica Spectrum Disorder often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Neuromyelitis Optica Spectrum Disorder trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.